Lv3
386 积分 2023-01-31 加入
CAR-T cell therapy for breast cancer: Current status and future perspective
1个月前
已完结
Relationship between homologous recombination deficiency and clinical features of breast cancer based on genomic scar score
1个月前
已完结
Association between homologous recombination deficiency status and carboplatin treatment response in early triple-negative breast cancer
1个月前
已完结
Impact of Homologous Recombination Deficiency on Outcomes in Patients With Triple-Negative Breast Cancer Treated With Carboplatin-Based Neoadjuvant Chemotherapy: Secondary Analysis of the NeoCART Randomized Clinical Trial
1个月前
已完结
Platinum-based chemotherapy in early-stage triple negative breast cancer: A meta-analysis
1个月前
已完结
Updated efficacy of adjuvant epirubicin plus cyclophosphamide followed by taxanes versus carboplatin plus taxanes in early triple-negative breast cancer in phase 2 trial: 8.1-year median follow-up
1个月前
已完结
Effect of adjuvant carboplatin intensified chemotherapy versus standard chemotherapy on survival in women with high risk, early stage, triple negative breast cancer (CITRINE): randomised, open label phase 3 trial
1个月前
已完结
Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Women With Triple-Negative Breast Cancer
1个月前
已完结
Early ctDNA and Survival in Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors
1个月前
已完结
Clinical application of circulating tumour DNA in colorectal cancer
1个月前
已完结
皖公网安备34019202002308
